Publications
2 shownLecanemab appropriate use recommendations for clinical practice in the UK
Lecanemab is an anti-amyloid monoclonal antibody, recently approved in the UK as a treatment for mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD...
Frequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 2
- Citations
- 714
- Institution
- Alzheimer Scotland
External Links
Identifiers
- ORCID
- 0000-0001-9797-2188
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.